{"podcast":{"title":"Gynecologic Oncology Update","slug":"gynecologic-oncology-update-612940","podcast_index_feed_id":612940,"rss_url":"https://feeds.captivate.fm/gynecologic-oncology/","website_url":"https://www.researchtopractice.com/browse-tumor-types/ovarian-cancer","image_url":"https://artwork.captivate.fm/aa2bde68-0d40-4e41-b73e-fff33f9524cf/gou-podcast-logo-3000px.png","author":"Dr. Neil Love","episode_count":46,"summary":"This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.","last_synced_at":"2026-07-21T08:21:50.117078+00:00","page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940"},"episode":{"title":"Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition","slug":"oncology-today-with-dr-neil-love-role-of-her2-directed-therapy-in-the-treatment-of-her2-expressing-gynecologic-cancers-part-1-of-a-special-3-part-edition","published_at":"2023-12-20T15:22:00+00:00","page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940/oncology-today-with-dr-neil-love-role-of-her2-directed-therapy-in-the-treatment-of-her2-expressing-gynecologic-cancers-part-1-of-a-special-3-part-edition","show_page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940","url":"https://gynecologic-oncology.captivate.fm/episode/oncology-today-with-dr-neil-love-role-of-her2-directed-therapy-in-the-treatment-of-her2-expressing-gynecologic-cancers-part-1-of-a-special-3-part-edition","audio_url":"https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/8b4116fe-5d6f-4f62-9de9-642d8d3a11f7/oncologytodayher2pantumor23-1gyn-converted.mp3","summary":"Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers.","meta_description":"Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3936,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/oncology-today-with-dr-neil-love-role-of-her2-directed-therapy-in-the-treatment-of-her2-expressing-gynecologic-cancers-part-1-of-a-special-3-part-edition/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940/oncology-today-with-dr-neil-love-role-of-her2-directed-therapy-in-the-treatment-of-her2-expressing-gynecologic-cancers-part-1-of-a-special-3-part-edition.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}